Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.27 USD
Change Today -0.20 / -1.38%
Volume 244.8K
RXDX On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan E. Lim M.D.

Co-Founder, Chairman, Chief Executive Officer and President,Ignyta, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Jonathan E. Lim, M.D. co-founded IGNYTA, Inc. and has been its President and Chief Executive Officer since August 2011. Dr. Lim is the Founder and Managing Partner at City Hill Ventures, LLC. He founded City Hill in December 2010. Dr. Lim founded Eclipse Therapeutics, Inc. and served as its Chairman and Chief Executive Officer. He served as an Executive Chairman of Eclipse Therapeutics, Inc. He served as the Chief Executive Officer, President, and Director of Halozyme ...

Read Full Background

Corporate Headquarters*

11111 Flintkote Avenue
San Diego, California 92121

United States

Phone: 858-255-5959
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer and President


Harvard University
Stanford University
Stanford University
McGill University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$608,333

Stock Options*

Exercisable Options115,971
Exercisable Options Value$184,819
Unexercisable Options317,362
Unexercisable Options Value$363,513
Total Value of Options$548,331
Total Number of Options433,333

Total Compensation*

Total Annual Cash Compensation$608,333
Total Short Term Compensation$608,333
Total Calculated Compensation$608,333
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXDX:US $14.27 USD -0.20


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGNYTA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at